Gut Microbiota And Radiotherapy
Sponsor: Abramson Cancer Center at Penn Medicine
A observational or N/A phase clinical study on Lung Tumor, this trial is completed. The trial is conducted by Abramson Cancer Center at Penn Medicine and has accumulated 13 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
-
Dec 2021 — May 2023 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
May 2020 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2019 — May 2020 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Jun 2018 — May 2019 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
For direct contact, visit the study record on ClinicalTrials.gov .